EGM
URGN icon

Engineers Gate Manager’s UroGen Pharma URGN Stock Holding History

Engineers Gate Manager’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,327
Closed -$225K – 2560
2025
Q1 		$225K Buy
20,327
+2,209
+12% +$23.6K ﹤0.01% 1839
2024
Q4 		$193K Sell
18,118
-2,022
-10% -$24.2K ﹤0.01% 1892
2024
Q3 		$256K Buy
20,140
+7,395
+58% +$110K 0.01% 1685
2024
Q2 		$214K Buy
12,745
+109
+0.9% +$1.55K ﹤0.01% 1622
2024
Q1 		$190K Sell
12,636
-974
-7% -$15.9K 0.01% 1656
2023
Q4 		$204K Buy
+13,610
New +$177K 0.01% 1633

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Engineers Gate Manager's URGN Position: Q2 2025 in Review

Engineers Gate Manager sold out of UroGen Pharma (URGN) in Q2 2025, closing a stake of 20,327 shares — an estimated $225K sold.

Engineers Gate Manager first reported a position in URGN in Q4 2023 and held it in 6 quarters. The position peaked at $256K in Q3 2024. 150 funds tracked by Wall St. Rank hold URGN as of Q2 2025.

  • Engineers Gate Manager reported no remaining UroGen Pharma position as of Q2 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 20,327 UroGen Pharma shares in Q2 2025, an estimated $225K.
  • Engineers Gate Manager first reported a position in UroGen Pharma in Q4 2023 and held it in 6 quarters.
  • Engineers Gate Manager's UroGen Pharma position peaked at $256K in Q3 2024.
  • 150 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2025.

Based on Engineers Gate Manager's 13F filing for Q2 2025, filed 14 Aug 2025.